| Literature DB >> 28824566 |
Chloe E Huseyin1,2,3, Raul Cabrera Rubio1,2, Orla O'Sullivan1,2, Paul D Cotter1,2, Pauline D Scanlan2.
Abstract
The human gut is host to a diverse range of fungal species, collectively referred to as the gut "mycobiome". The gut mycobiome is emerging as an area of considerable research interest due to the potential roles of these fungi in human health and disease. However, there is no consensus as to what the best or most suitable methodologies available are with respect to characterizing the human gut mycobiome. The aim of this study is to provide a comparative analysis of several previously published mycobiome-specific culture-dependent and -independent methodologies, including choice of culture media, incubation conditions (aerobic versus anaerobic), DNA extraction method, primer set and freezing of fecal samples to assess their relative merits and suitability for gut mycobiome analysis. There was no significant effect of media type or aeration on culture-dependent results. However, freezing was found to have a significant effect on fungal viability, with significantly lower fungal numbers recovered from frozen samples. DNA extraction method had a significant effect on DNA yield and quality. However, freezing and extraction method did not have any impact on either α or β diversity. There was also considerable variation in the ability of different fungal-specific primer sets to generate PCR products for subsequent sequence analysis. Through this investigation two DNA extraction methods and one primer set was identified which facilitated the analysis of the mycobiome for all samples in this study. Ultimately, a diverse range of fungal species were recovered using both approaches, with Candida and Saccharomyces identified as the most common fungal species recovered using culture-dependent and culture-independent methods, respectively. As has been apparent from ecological surveys of the bacterial fraction of the gut microbiota, the use of different methodologies can also impact on our understanding of gut mycobiome composition and therefore requires careful consideration. Future research into the gut mycobiome needs to adopt a common strategy to minimize potentially confounding effects of methodological choice and to facilitate comparative analysis of datasets.Entities:
Keywords: fungi; gut microbiota; healthy; human; methodology; mycobiome; mycobiota
Year: 2017 PMID: 28824566 PMCID: PMC5534473 DOI: 10.3389/fmicb.2017.01432
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Participant information and selected culture dependent results.
| Study participant | Age | Mean fungal counts CFU g-1 ±SD | Pure-culture isolate classification (closest relative on database) |
|---|---|---|---|
| F1 | 41/42 | 3.83 × 103 ± 5.26 × 102 | |
| Uncultured | |||
| F2 | 35 | 1.25 × 102 ± 1.66 × 102 | |
| F3 | 29 | 1.67 × 102 ± 2.15 × 102 | |
| Uncultured | |||
| Uncultured | |||
| 46 | 2.11 × 103 ± 5.05 × 102 | + | |
| F5 | 30 | 8.33 × 100 ± 2.89 × 101 | |
| F6 | 24 | 1.36 × 103 ± 4.36 × 102 | |
| F7 | 25 | 0 ± 0 | No isolates |
| F8 | 38 | 1.67 × 102 ± 1.15 × 102 | |
| 35 | 3.44 × 103 ± 1.93 × 103 | ||
| + | |||
| + | |||
| M1 | 39 | 3.75 × 105± 8.14 × 104 | |
| Uncultured | |||
| Uncultured | |||
| M2 | 25 | 2.9 × 103 ± 8.97 × 102 | |
| M3 | 49 | 2.63 × 103 ± 8.43 × 102 | |
| Uncultured | |||
| M4 | 28 | 0 ± 0 | No isolates |
| M5 | 25 | 8.33 × 100 ± .89 × 101 | No sequences passed quality control |
| M6 | 39 | 6.68 × 103 ± 1.07 × 103 | |
| Uncultured | |||
| 36 | 6.49 × 104 ± 8.03 × 103 | ||
| + | |||
| +Uncultured | |||
| M8 | 37 | 3.33 × 101 ± 4.92 × 101 | |
| 55 | 8.38 × 103 ± 1.18 × 103 | + | |
| ˆUncultured Saccharomycetales | |||
Extraction methods used in this study.
| Method | Abbreviation used in paper | Reference | |
|---|---|---|---|
| QIAamp Fast DNA Stool Mini Kit | As per manufacturer’s instructions | Q | |
| QIAamp Fast DNA Stool Mini Kit and Bead beating | As per manufacturer’s instructions with addition of 3× 1 min bead beats with 1 min incubation on ice in-between each bead beat. | BB | |
| QIAamp Fast DNA Stool Mini Kit and Lyticase lysis buffer | Thirty minute incubation using the lysis buffer described in ( | LYT | |
| FastDNA® SPIN Kit | As per manufacturer’s instructions for yeast using buffer CLS-Y. | F | |
| RBBC (Repeat bead beating + column) | As described in ( | RBBC or R used in some graphs for brevity | |
Primers used in this study.
| Primer pair (forward and reverse) | Sequence forward (5′→3′) | Sequence reverse (5′→3′) | Target region | Ability to generate PCR product (using DNA from 6 participants × 3 methods) | Reference |
|---|---|---|---|---|---|
| ITS1F and ITS2 | CTTGGTCATTTAGAGGAAGTAA | GCTGCGTTCTTCATCGATGC | ITS1 | PCR products from 6/6 BB, 5/6 LYT, and 6/6 RBBC samples | |
| ITS1F and ITS4 | CTTGGTCATTTAGAGGAAGTAA | TCCTCCGCTTATTGATATGC | Entire ITS | PCR products from 1/6 BB, 1/6 LYT, and 3/6 RBBC samples | |
| BITS and B58S3 | ACCTGCGGARGGATCA | GAGATCCRTTGYTRAAAGTT | PCR products from 0/6 BB, 0/6 LYT, and 0/6 RBBC samples | ||
| ITS5 and ITS2 | GGAAGTAAAAGTCGTAACAAGG | GCTGCGTTCTTCATCGATGC | ITS1 | PCR products from 3/6 BB, 4/6 LYT, and 3/6 RBBC samples | |
| ITS1F _KY01 and ITS2 _KY01 | CTHGGTCATTTAGAGGAASTAA | CTRYGTTCTTCATCGDT | ITS1 | PCR products from 0/6 BB, 0/6 LYT, and 0/6 RBBC samples | |
| ITS1F _KY02 and ITS2 _KY02 | TAGAGGAAGTAAAAGTCGTAA | TTYRCTRCGTTCTTCATC | ITS1 | PCR products from 1/6 BB, 1/6 LYT, and 1/6 RBBC samples | |
| UNI1 and UNI2 | ATGAAGAACGCAGCGAAATGCGATA | GTTGGTTTCTTTTCCTCC | ITS2 | PCR products from 4/6 BB, 4/6 LYT, and 2/6 RBBC samples | |
| FSEQ and RSEQ | ATGCCTGTTTGAGCGTC | CCTACCTGATTTGAGGTC | ITS2 | PCR products from 4/6 BB, 4/6 LYT, and 3/6 RBBC samples | |
| ITS1F and ITS2 with | ITS1 | As for ITS1F and ITS2 | |||